Insider Transactions Reported by 9 Insiders of BIOXYTRAN, INC

Symbol
BIXT on OTC
Location
Needham, MA

Key facts

  • BIXT - BIOXYTRAN, INC has 9 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are available for direct filing-level review.

Change

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Research use

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 25 May 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

BIOXYTRAN, INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
David Platt CEO, Director, 10%+ Owner $12,882,399 Mixed 25 Oct 2024
Michael Sheikh CCO, 10%+ Owner $4,477,022 Mixed 25 Oct 2024
Binder Offer 10%+ Owner $1,721,400 Mixed 31 Dec 2021
Alan M. Hoberman Director $145,672 Mixed 12 Aug 2025
Dale H. Conaway Director $132,711 Mixed 12 Aug 2025
Anders Utter Director $130,402 Mixed 14 Nov 2025
Radka Milanova Director $71,290 Mixed 12 Aug 2025
Ola Soderquist CFO, 10%+ Owner $69,882 Mixed 25 Oct 2024
Hana Chen-Walden Director Mixed 31 Dec 2023

Top shareholders of BIOXYTRAN, INC (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
David Platt
3/4/5
CEO, Director, 10%+ Owner $12,882,399 25 Oct 2024
Michael Sheikh
3/4/5
CCO, 10%+ Owner
class O/S missing
8,214,720
$4,477,022 25 Oct 2024
Binder Offer
3/4/5
10%+ Owner
class O/S missing
8,919,169
$1,721,400 31 Dec 2021
Ola Soderquist
3/4/5
CFO, 10%+ Owner
mixed-class rows
14,376,456
mixed-class rows
$69,882 25 Oct 2024
Alan M. Hoberman
3/4/5
Director
mixed-class rows
626,207
mixed-class rows
$145,672 12 Aug 2025
Dale H. Conaway
3/4/5
Director
class O/S missing
379,177
$132,711 12 Aug 2025
Anders Utter
3/4/5
Director
class O/S missing
372,580
$130,402 14 Nov 2025
Radka Milanova
3/4/5
Director
class O/S missing
203,688
$71,290 12 Aug 2025

Recent Insider Transactions by Companies or Individuals for BIOXYTRAN, INC

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Alan M. Hoberman BIXT common Purchase 210,000 210,000 18 Nov 2025 Direct
Alan M. Hoberman BIXT preferred Award 10.2% 38,588 416,207 14 Nov 2025 Direct
Radka Milanova BIXT preferred Award 23.4% 38,588 203,688 14 Nov 2025 Direct
Dale H. Conaway BIXT preferred Award 11.3% 38,588 379,177 14 Nov 2025 Direct
Anders Utter BIXT preferred Award 11.6% 38,588 372,580 14 Nov 2025 Direct
Alan M. Hoberman BIXT preferred Award 2.84% 10,417 377,619 12 Aug 2025 Direct
Radka Milanova BIXT preferred Award 6.73% 10,417 165,100 12 Aug 2025 Direct
Dale H. Conaway BIXT preferred Award 3.16% 10,417 340,589 12 Aug 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .